Tag: Russia
Lupin receives positive CHMP opinion for Biosimilar Ranibizumab
Ranibizumab is a recombinant humanized IgG1 monoclonal antibody fragment that binds to and inhibits vascular endothelial growth factor A (VEGF-A)
AiMeD & DRISP collaboration gives boost to Indo Russian medical device...
The experts from India and Russia stressed the need for a dynamic and multifaceted economic engagement at a recently held webinar
AiMeD, DRISP join hands to promote medical device industry in India...
The two organizations will share info on trade, investment and technology transfer opportunities and trends
One shot Sputnik Light vaccine gets approval in India
The Russian vaccine has been authorized in more than 30 countries with total population of over 2.5 billion people
One-shot Sputnik Light vaccine demonstrates 70% efficacy against infection with Delta...
The one-shot Sputnik Light vaccine is authorized in more than 15 countries, with ongoing registration processes in another 30 countries.......................
Sputnik V could accelerate the vaccination drive in India
With more people coming forward to get vaccinated, the Russian vaccine could help in sharing the load, writes Prof. Ashok Rattan, Advisor, PathKind Labs.....................
Sputnik V vaccine authorized in India
India has become the 60th country to approve the Russian vaccine, Sputnik V, one of only three vaccines registered so far in the country.........................
Panacea Biotec to produce 100 million doses of Sputnik V vaccine
The move is expected to facilitate the global supply of Sputnik V vaccine to international partners of the Russian Direct Investment Fund (RDIF).................................
First batch of Sputnik V vaccine delivered to Mexico
Sputnik V is approved for use in more than 30 countries making the vaccine one of the world's top three coronavirus vaccines in terms of the number of approvals issued by regulatory authorities.....................
RDIF & Hetero agree to produce 100 million doses of the...
Currently, Phase III clinical trials are approved and are ongoing in Belarus, the UAE, Venezuela and other countries, as well as Phase II-III in India..........................